Subscribe to Newsletter

Manufacture

Manufacture Contract Manufacturing Services

The Customer View

| Sponsored by MilliporeSigma

Samsung Biologics give their opinion on working with the M Lab™ Collaboration Centers.

Manufacture Bioprocessing - Upstream & Downstream

Single-Pass Promise

| Torsten Bisschop, Matteo Costioli

When EMD Serono wanted to increase drug production, they found that their manufacturing process did not have the required capacity.

Manufacture Technology and Equipment

Safety in Numbers

| Sladjana Tomic-Skrbic, Gregory Voyta

Viral contamination can shut down a plant for months – affecting manufacturing, causing business disruption and threatening supply and patient safety.

Manufacture Bioprocessing - Single Use Systems

On the Cusp of Curing Disease

| Elizabeth Goodrich, Ranjeet Patil

Welcome to the M Lab™ Collaboration Centers – where customers can use non-GMP lab spaces to operate equipment, evaluate processes and receive...

Manufacture Contract Manufacturing Services

Welcome to the M Lab™ Collaboration Centers!

| Chin Bin Tan

Enter a space where you can explore new ideas, learn innovative techniques, and work side by side with technical experts

Manufacture Standards & Regulation

Quality, Not Quantity

| Iain Moore

Qualitative risk assessments are a great way to approach quality management and train your operators at the same time.

Manufacture Technology and Equipment

Your Digital Twin

| Stephanie Vine

By simulating processes in a digital twin of a facility, changes can be safely tested before application in the real world.

Manufacture Small Molecules

Getting into Granulation

| Stephanie Vine

Dry granulation offers several advantages to manufacturers and it’s now attracting more attention with the push towards continuous manufacturing.

Manufacture Dosage Forms

Additive Benefits

| Hatim Cader

Will 3D inkjet printing enable the manufacture of personalized tablets?

Manufacture Technology and Equipment

A Smarter – and Synthetic – Workflow for Bioengineering

| Maryam Mahdi

Can artificial approaches trump the conventions of traditional organic synthesis for the production of raw pharmaceutical products within cells?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register